Testing effectiveness (Phase 2)Study completedNCT00186667
What this trial is testing
Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease
Who this might be right for
Graft vs Host DiseaseBlood and Marrow Transplant (BMT)
Stanford University 30